MAPK8 and metabolic dysfunction-associated steatohepatitis: The prolonged activation of JNK could be alleviated by NF-κB-mediated upregulation of anti-apoptotic genes, such as Bcl-xl and cFLIP (82), which may be a therapeutic strategy for NASH.